Beyond Meat: Analysts Lower Price Targets Following Disappointing Earnings

Beyond Meat (NASDAQ: BYND) has been a laggard this year, with its year-to-date performance currently sitting at -16.8%. Most of the drop has happened this week after the company reported less than stellar earnings slumping its share price about 13% since. The company reported revenues of $108.2 million, a 6.1% quarter-over-quarter increase, yet results came in lower than analysts’ estimates. The company reported a 30.2% gross margin and an ($0.43) earnings per share.

A few analysts changed their price targets on Beyond Meat, lowering its average 12-month target price from $128.80 to $120.87.

Canaccord Genuity was one of the investment banks to lower their 12-month price target on Beyond Meat to $125 from $155 and they reiterated their hold rating on the company. Bobby Burleson says that margins remained compressed this quarter due to a sustained investment cycle, mix-shift headwinds and COVID continued to impact the company. On the share price, he believes that the companies shares will remain range-bound until “a meaningful rebound in Foodservice materializes,” and adds, “We feel the near term set up warrants continued caution on the stock, as additional downward revisions to EBITDA may be required.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Beyond’s revenue of $108 million and EBITDA of ($10.8) million came in lower than Canaaccord’s estimates of $114.5 million and ($3.4) million respectively. Burleson says that the main driver as to why the company did not beat expectations was because of higher operating expenses and mix shift impact while operating costs grew due to an increase in production trial activities, higher shipping and freight costs, and an increased headcount. He writes, “The company remains caution and continues to refrain from providing full-year 2021 guidance.”

On a lighter note, The company does seem to be improving its market share and market penetration. Burleson writes, “its household penetration rate improved sequentially and Y/Y in Q1 by 10 and 100 bps, respectively, to 5.4%, while buyer rate, purchase frequency, and repeat rate all increased Q/Q and Y/Y.” Additionally, Beyond Meats market share is also up 16% year over year and continues to hold the #1 position based on dollar volume for broad-line distribution.

Below you can see Canaccord’s 2021-2022 estimate changes.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Golden Cariboo’s First Quesnelle Resource Estimate Tallies 1.19 Million Gold Equivalent Ounces

Brixton Wraps Camp Creek Drilling With 17.58 Metres of 1.47 g/t Gold Equivalent

Related News

Teladoc: Mixed Results From Analysts Following Q4 Results

On February 24th, Teladoc Health (NYSE: TDOC) reported their full-year and fourth quarter results. Fourth...

Friday, February 26, 2021, 04:06:40 PM

Canopy Growth Sees Canaccord Cut Price Target To Just $4.50 After Terrible Q4 Results

On May 27, Canopy Growth (TSX: WEED) reported its fiscal fourth-quarter financial results for the...

Sunday, June 5, 2022, 11:18:00 AM

Aurora: Canaccord Raises Price Target To $14.00 On Back Of Earnings

Last night, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported its second quarter 2020 earnings. They...

Friday, February 12, 2021, 04:02:00 PM

Meta Platforms: BMO Calls The Bottom, Saying “Sell-Off Feels Overdone”

Meta Platforms (NASDAQ: FB), which is reporting its first-quarter results on April 27, is just...

Monday, April 25, 2022, 04:22:00 PM

Columbia Care Sees Consensus Price Target Rise To $14.70

On August 12, Columbia Care Inc. (CSE: CCHW) reported its second-quarter financial results, wherein the...

Wednesday, August 18, 2021, 10:09:00 AM